Comparison of measurements of anti-PLA2R antibodies in Japanese patients with membranous nephropathy using in-house and commercial ELISA

H Kaga, A Komatsuda, S Yamamoto, T Kikuchi… - Clinical and …, 2019 - Springer
Background The prevalence of antibodies against M-type anti-phospholipase A2 receptor
(PLA2R) was reported to be~ 70–80% in early studies on idiopathic membranous …
被引用次数：11 相关文章

Comparison of measurements of anti-PLA2R antibodies in Japanese patients with membranous nephropathy using in-house and commercial ELISA

H Kaga, A Komatsuda, S Yamamoto… - Clinical and …, 2019 - pubmed.ncbi.nlm.nih.gov
Background The prevalence of antibodies against M-type anti-phospholipase A2 receptor
(PLA2R) was reported to be~ 70-80% in early studies on idiopathic membranous …

Comparison of measurements of anti-PLA2R antibodies in Japanese patients with membranous nephropathy using in-house and commercial ELISA

H Kaga, A Komatsuda, S Yamamoto… - Clinical and …, 2019 - search.proquest.com
Background The prevalence of antibodies against M-type anti-phospholipase A2 receptor
(PLA2R) was reported to be~ 70–80% in early studies on idiopathic membranous …

Comparison of measurements of anti-PLA2R antibodies in Japanese patients with membranous nephropathy using in-house and commercial ELISA.

H Kaga, A Komatsuda, S Yamamoto… - Clinical and …, 2019 - europepmc.org
Background The prevalence of antibodies against M-type anti-phospholipase A2 receptor
(PLA2R) was reported to be~ 70-80% in early studies on idiopathic membranous …
[PDF] researchmap.jp

[PDF][PDF] Comparison of measurements of anti-PLA2R antibodies in Japanese patients with membranous nephropathy using in-house and commercial ELISA

H Kaga, A Komatsuda, S Yamamoto… - Clinical and …, 2019 - researchmap.jp
Background The prevalence of antibodies against M-type anti-phospholipase A2 receptor
(PLA2R) was reported to be~ 70–80% in early studies on idiopathic membranous …

Comparison of measurements of anti-PLA2R antibodies in Japanese patients with membranous nephropathy using in-house and commercial ELISA.

H Kaga, A Komatsuda, S Yamamoto… - Clinical & …, 2019 - search.ebscohost.com
Background: The prevalence of antibodies against M-type anti-phospholipase A2 receptor
(PLA2R) was reported to be~ 70–80% in early studies on idiopathic membranous …